Nov. 22, 2021 – As the COVID-19 pandemic continues, the American Medical Association (AMA) is stepping up efforts to stop the dangerous spread of information, particularly when it comes from healthcare professionals (HCPs) who are using their licenses to validate the disinformation they are spreading. This scenario – where HCPs deliberately make false claims about […]
Read more
July 31, 2017 — Guest commentary by Michael Parenti America’s opioid crisis is a major issue and the subject of ongoing debate. But before we can begin to tackle this problem, we need to take a look at the policy decisions that got us here. War has a way of embedding itself within the public consciousness. […]
Read moreJuly 15, 2016 – More than 100 medical associations, including the American Medical Association, signed a letter of support for S. 2978, a bill sponsored by Sen. John Barrasso, M.D. (R-Wyo.), that would exempt peer-reviewed journals, journal reprints, journal supplements, medical conference reports, and medical textbooks from being reported as transfers of value under the […]
Read moreNov. 17, 2015 — The American Medical Association (AMA) announced today that it would support an advertising ban on direct-to-consumer (DTC) advertising in an effort to make prescription drugs more affordable and address member concerns regarding “the negative impact of commercially-driven promotions and the role that marketing costs play in fueling escalating drug prices.” The […]
Read moreJune 12, 2014 – The American Medical Association’s (AMA’s) House of Delegates is attempting to bring some common sense to the Sunshine Act final rules, passing two resolutions at the AMA 2014 annual meeting this week that call on the AMA to work with the Centers for Medicare & Medicaid Services (CMS) to add a […]
Read moreNov. 19, 2012 – At its recent Interim Meeting, the American Medical Association’s (AMA’s) House of Delegates voted to clarify the AMA’s ethical guidance on continuing medical education (CME), according to a Nov. 16 posting on Policy and Medicine. The AMA’s Council on Ethical and Judicial Affairs (CEJA) made revisions that are consistent with many […]
Read moreThe AMA”s CME Task Force recently issued its latest Fact Sheet, “On-Label and Off-label Usage of Prescription Medicines and Devices, and the Relationship to CME.” Expert Tom Sullivan discusses this important issue in his blog, Policy and Medicine:
Read moreThe Council on Ethical and Judicial Affairs (CEJA) of the American Medical Association (AMA) has recently submitted a report titled “Financial Relationships with Industry in Continuing Medical Education” to a reference committee of the AMA, to be considered for submission to the AMA House of Delegates on June 14th. Although the report is less stifling […]
Read more